- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05114382
An Evaluation of the Safety and Performance of the CathVision Cube® System
Studieoversigt
Detaljeret beskrivelse
A prospective, single center, open-label, single arm study to evaluate the safety and technical performance of the CathVision Cube® system.
Patients undergoing assessment and ablation of cardiac arrhythmias, by Electro Physiology (EP) procedure, and who meet all inclusion criteria will be enrolled in the study and undergo the EP procedure. Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with a commercial (CE marked) EP recording system and later compared and evaluated. The investigational device will not be used for direct clinical care decisions or therapy. The EP procedure will be guided by the study site Standards Of Care.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patient indicated by investigator for catheter ablation or diagnostic electrophysiology procedure.
- Male or non-pregnant female aged ≥18 years. Female patients of childbearing potential must have a negative pregnancy test (per site standard test) within 7 days prior to index procedure.
- Able and willing to directly provide informed consent.
Exclusion Criteria:
- Patient inability to understand or refusal to sign informed consent.
- Pregnant or nursing patients and those who plan pregnancy in the period up to 1 month following the index procedure.
- Current participation in another investigational drug or device study that interferes with this study.
- Patient is a prisoner.
- Patients who in the opinion of the physician are not candidates for this study. Prior atrial septal defect (ASD) or patent foramen ovale (PFO) closure with a device using a transcatheter percutaneous approach.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Andet: A prospective, multi-center, open-label, single arm study
Patients undergoing assessment and ablation of cardiac arrhythmiast.
who are scheduled for an electrophysiology (EP) procedure and meet all inclusion criteria will be enrolled in the study and undergo the EP procedure.
Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with the commercial (CE marked) EP recording system for post procedure evaluation.
The investigational device will not be used for direct clinical care decisions or therapy.
The EP procedure will be guided by the study site Standards Of Care.
|
Intracardiac signals will be passively recorded using CathVision Cube® System in parallel with the commercial (CE marked) EP recording system during a scheduled electrophysiology procedure
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Freedom from major adverse events, evaluated at hospital discharge.
Tidsramme: From EP procedure to hospital discharge is 1 day
|
Freedom from major adverse events, evaluated at hospital discharge
|
From EP procedure to hospital discharge is 1 day
|
Recording low-voltage electrograms
Tidsramme: Duration of the EP procedure can take up to 6 hours
|
Recording low-voltage electrograms under 20uV amplitude
|
Duration of the EP procedure can take up to 6 hours
|
The Primary Performance endpoint of study will be evaluated as technical success of CathVision Cube® system to collect and record intracardiac signals during EP procedures
Tidsramme: Duration of the EP procedure can take up to 6 hours
|
Logging time for arrhythmia termination / block
|
Duration of the EP procedure can take up to 6 hours
|
Compatibility of Cube System with commercially available 3D mapping system
Tidsramme: Duration of the EP procedure can take up to 6 hours
|
Assessing compatibility of Cube System with commercially available 3D mapping system with available intracardiac catheters.
Compatibility is assessed by that the Cube System does not introduce a visual detectable distortion on the commercial available 3D mapping systems
|
Duration of the EP procedure can take up to 6 hours
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Josef Kautzner, Prof., IKEM, Prague, Czech Republic
- Ledende efterforsker: Peter K Jacobsen, MD, DMSc, Righospitalet, Copenhagen, Denmark
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CP-00003
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjertearytmi
-
Impulse DynamicsRekrutteringEvaluer sikkerheden og anvendeligheden af ODOCOR II Intra-cardiac LeadSpanien, Tyskland, Italien
-
Abbott Medical DevicesAfsluttetPatienten opfylder ACC/AHA/ESC-retningslinjerne for implanterbar cardioverter-defibrillator (ICD) eller cardiac resynchronization therapy (CRT-D)-enhedDet Forenede Kongerige, Tyskland
-
Reham SameehAssiut UniversityUkendtCardiac Magnetic Resonance Imaging i ikke-iskæmisk kardiomyopati
-
Milton S. Hershey Medical CenterRekrutteringVenstre ventrikulær dysfunktion | Spinalbedøvelsesmidler, der forårsager uønskede virkninger ved terapeutisk brug | Global Cardiac Wall Motion DysfunktionForenede Stater
-
Russian Federation of Anesthesiologists and ReanimatologistsRekrutteringPost Cardiac Arrest SyndromeDen Russiske Føderation
-
University of AarhusAfsluttetHjertestop | Hypotermi | Post Cardiac Arrest SyndromeDanmark
-
University of AarhusUkendtHjertestop uden for hospitalet | Post Cardiac Arrest SyndromeDanmark
-
Ospedale San Giovanni BellinzonaSwiss Heart FoundationAfsluttetAkut myokardieinfarkt | Takotsubo kardiomyopati | Cardiac X syndromSchweiz
-
University Medical Center GroningenUkendtAkutmedicinske tjenester | Hjertestop uden for hospitalet | Post Cardiac Arrest Syndrome
-
University of FlorenceSandro Gelsomino; Edvin Prifti; Francesco Cabrucci; Marco Bugetti; Orlando Parise og andre samarbejdspartnereRekrutteringKardiogent stød | Ekstrakorporal membraniltningskomplikation | Post-hjertekirurgi | Ekstrakorporal livsstøtte | Post Cardiac Arrest SyndromeItalien
Kliniske forsøg med EP Procedure
-
eXIthera PharmaceuticalsTrukket tilbageCovid19 | TrombopeniForenede Stater
-
National Institute of Allergy and Infectious Diseases...AfsluttetHIV-infektionerForenede Stater
-
Region StockholmKarolinska InstitutetTilmelding efter invitationEpilepsi | Mitokondrielle sygdomme | Motor neuron sygdom | Metabolisk sygdom | LHON | Epilepsi hos børn
-
BioSig Technologies, Inc.Afsluttet
-
Esperance Pharmaceuticals IncAfsluttetAvancerede solide tumorer | Faste tumorerForenede Stater
-
Boston Scientific CorporationAfsluttet
-
Kansas City Heart Rhythm Research FoundationIkke rekrutterer endnuHjertearytmierForenede Stater
-
John SappNova Scotia Health Authority; Rochester Institute of TechnologyRekrutteringMyokardieinfarkt | Ventrikulær takykardiCanada
-
Abbott Medical DevicesAfsluttetHjertefejl | HjertearytmiForenede Stater, Spanien, Tyskland, Holland, Estland, Canada, Østrig, Australien